BlackRock Investment Management, LLC - JUNIPER PHARMACEUTICALS INC ownership

JUNIPER PHARMACEUTICALS INC's ticker is JNP and the CUSIP is 48203L107. A total of 45 filers reported holding JUNIPER PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of JUNIPER PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$10,0000.0%1,8480.0%0.00%
Q3 2016$10,000
-23.1%
1,8480.0%0.00%
Q2 2016$13,000
+8.3%
1,8480.0%0.00%
Q1 2016$12,000
-36.8%
1,8480.0%0.00%
Q4 2015$19,000
-9.5%
1,848
+3.4%
0.00%
Q3 2015$21,000
+31.2%
1,7880.0%0.00%
Q2 2015$16,0001,7880.00%
Other shareholders
JUNIPER PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
JW Asset Management, LLC 328,132$1,821,0001.25%
Stonepine Capital Management, LLC 173,967$966,0000.79%
Krensavage Asset Management, LLC 288,294$1,600,0000.58%
ALGERT GLOBAL LLC 79,745$443,0000.13%
HEARTLAND ADVISORS INC 400,000$2,220,0000.13%
PERRITT CAPITAL MANAGEMENT INC 27,950$155,0000.04%
Spark Investment Management LLC 48,400$268,0000.02%
TFS CAPITAL LLC 14,707$82,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 180,200$1,000,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 36,210$201,0000.01%
View complete list of JUNIPER PHARMACEUTICALS INC shareholders